Chrysoeriol Suppresses Hepatocellular Carcinoma Progression Through Blocking Activation of IL-6/JAK/STAT3 Signaling
The Tohoku Journal of Experimental Medicine · 2025
DOI: 10.1620/tjem.2025.j147 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2025. Verfasst von Hanqing Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First College of Clinical Medical Science, China Three Gorges University. Hauptthemen laut MEDLINE: Liver Neoplasms, STAT3 Transcription Factor, Carcinoma, Hepatocellular, Signal Transduction.
Abstract (Originalsprache)
Chrysoeriol, a natural flavonoid, has demonstrated broad antitumor properties across multiple cancer types.This study aims to elucidate its specific functions and the molecular mechanisms underlying its antitumor effects in hepatocellular carcinoma (HCC).We employed a series of experimental approaches: in vitro assays including Cell Counting Kit-8, colony formation, Transwell, wound healing, flow cytometry, immunofluorescence, tube formation, and Western blot using HCC cell lines; in vivo models comprised mouse xenograft and metastatic models, with tumor progression assessed through size, weight, immunohistochemistry, hematoxylin-eosin staining, and Western blot.Our results indicated that chrysoeriol significantly suppressed HCC cell proliferation, metastasis, and angiogenesis while promoting apoptosis.Specifically, chrysoeriol treatment led to a noticeable decrease in cell viability and colony-forming ability, impeded migratory and invasive behaviors, and induced apoptotic cell death in HCC cells.In vivo, chrysoeriol administration markedly inhibited tumor growth and reduced the number of lung metastatic nodules.Mechanistically, chrysoeriol effectively blocked IL-6-induced activation of signal transducer and activator of transcription 3 (STAT3) and suppressed phosphorylation of Janus kinase 1/2 (JAK1/2).Furthermore, the compound attenuated migration and tube formation in human umbilical vein endothelial cells, and decreased microvessel density in tumor tissues.Overall, these findings demonstrate that chrysoeriol exerts multifaceted antitumor effects in HCC through suppression of the IL-6/JAK/STAT3 signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First College of Clinical Medical Science, China Three Gorges University.
- Institute of Hepatobiliary and Pancreatic Surgery, China Three Gorges University.
- Yichang Central People's Hospital.
Zitieren
APA
Hu, H., Zheng, X., Tian, G., Lu, L., & Yao, R. (2025). Chrysoeriol Suppresses Hepatocellular Carcinoma Progression Through Blocking Activation of IL-6/JAK/STAT3 Signaling. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.2025.j147
Vancouver
Hu H, Zheng X, Tian G, Lu L, Yao R. Chrysoeriol Suppresses Hepatocellular Carcinoma Progression Through Blocking Activation of IL-6/JAK/STAT3 Signaling. The Tohoku Journal of Experimental Medicine. 2025. doi:10.1620/tjem.2025.j147
BibTeX
@article{Hu2025,
author = {Hu, Hanqing and Zheng, Xin and Tian, Guodong and Lu, Ling and Yao, Rucheng},
title = {Chrysoeriol Suppresses Hepatocellular Carcinoma Progression Through Blocking Activation of IL-6/JAK/STAT3 Signaling},
journal = {The Tohoku Journal of Experimental Medicine},
year = {2025},
doi = {10.1620/tjem.2025.j147}
}
EUVIMED